Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 51–100 of 174 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06695845	A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors	recruiting	Phase 2	200	Jazz PharmaceuticalsINDUSTRY	3	Jul 10, 2026	clinicaltrials
NCT04774419	Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery	recruiting	Phase 2	62	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 9, 2026	clinicaltrials